Franchi Jean M. 4

What Happened Jean M. Franchi, Chief Financial Officer of Disc Medicine, sold 353 shares in open-market transactions on February 25, 2026. The shares were sold at a weighted average price of $69.06, resulting in gross proceeds of approximately $24,377. This was a sale (transaction code S), which is commonly routine insider selling rather than a purchase signal.

Key Details

• Transaction date: February 25, 2026 (reported on Form 4 filed February 27, 2026).
• Price: Weighted average $69.06 per share; individual trades ranged from $69.00 to $69.36 (footnote).
• Shares sold: 353; Total value: ~$24,377.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: (F1) Sale effected under a Rule 10b5-1 trading plan adopted Sept 25, 2025. (F2) Weighted average price; reporting person can provide per-trade breakdown on request.
• Timeliness: Form 4 filed two days after the transaction date; appears to be filed within the standard two-business-day window.

Context Because the sale was made under a pre-established 10b5-1 plan, the trades were likely pre-arranged and may not reflect the insider’s contemporaneous view of the company. For retail investors, routine sales under such plans are common and should be weighed alongside other insider activity and company fundamentals.